文献速递肝病消化道肿瘤与早癌

高迁移率族蛋白B1通过Yes相关蛋白依赖性有氧糖酵解控制肝癌发生

High mobility group protein B1 controls liver cancer initiation through yes-associated protein -dependent aerobic glycolysis.
PubMed 文献 · Hepatology · 2018-04-01

该研究探讨高迁移率族蛋白B1(HMGB1)在肝细胞癌(HCC)发生中的作用机制。小鼠实验中,Cre/loxP重组介导的肝细胞HMGB1缺失阻断二乙基亚硝胺诱导的肝癌发生;HMGB1与GA结合蛋白α结合促进Yes相关蛋白(YAP)表达,进而诱导缺氧诱导因子1α(HIF1α)依赖性有氧糖酵解。靶向HMGB1-YAP-HIF1α通路可抑制过度糖酵解和肿瘤生长。

要点

  • 肝细胞HMGB1缺失阻断二乙基亚硝胺诱导的小鼠肝癌发生。
  • HMGB1与GA结合蛋白α结合促进YAP表达,YAP通过HIF1α依赖性有氧糖酵解促进肝肿瘤发生。
  • 遗传或药物抑制HMGB1-YAP-HIF1α通路可抑制小鼠过度糖酵解和肿瘤生长。

核心结论

  • HMGB1在调控YAP依赖性HIF1α通路中发挥新作用,为HCC化学预防的代谢靶向治疗开发提供线索。

研究设计与样本

  • 研究采用Cre/loxP重组介导的肝细胞HMGB1缺失小鼠模型、二乙基亚硝胺诱导肝癌模型、短发夹RNA介导的HMGB1基因沉默HCC细胞实验及YAP敲低HCC细胞系实验。

主要发现

  • 肝细胞HMGB1缺失阻断二乙基亚硝胺诱导的小鼠肝癌发生,短发夹RNA介导的HMGB1基因沉默抑制HCC细胞增殖。
  • HMGB1与GA结合蛋白α结合促进YAP表达,YAP通过诱导HIF1α依赖性有氧糖酵解促进肝肿瘤发生。
  • YAP-5SA-S94A与野生型YAP互补DNA一样,可在YAP敲低HCC细胞系中恢复HIF1α DNA结合活性、糖酵解相关基因表达及HIF1α-YAP复合物形成。
  • 维替泊芬(verteporfin)可阻断YAP-HIF1α复合物形成;遗传或药物抑制HMGB1-YAP-HIF1α通路可抑制小鼠过度糖酵解和肿瘤生长。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Emerging studies have suggested that the Hippo pathway is involved in the tumorigenesis of hepatocellular carcinoma (HCC). However, the key regulator of the Hippo pathway in liver tumor metabolic reprogramming remains elusive. Here, we provide evidence that high mobility group box 1 (HMGB1), a chromosomal protein, plays a role in the regulation of the Hippo pathway during liver tumorigenesis. Cre/loxP recombination-mediated HMGB1 depletion in hepatocytes blocks diethylnitrosamine-induced liver cancer initiation in mice, whereas short hairpin RNA-mediated gene silencing of HMGB1 inhibits HCC cell proliferation. Mechanistically, the binding of HMGB1 to GA-binding protein alpha promotes the expression of yes-associated protein (YAP), a major downstream effector of the Hippo pathway that contributes to liver tumorigenesis by inducing hypoxia-inducible factor 1α (HIF1α)-dependent aerobic glycolysis. Like wild-type YAP-complementary DNA, YAP-5SA-S94A can restore HIF1α DNA binding activity, glycolysis-associated gene expression, and HIF1α-YAP complex formation in YAP-knockdown HCC cell lines. In contrast, verteporfin, a reagent targeting the interface between YAP and TEA domain transcription factor, has the ability to block YAP-HIF1α complex formation. Notably, genetic or pharmacologic inhibition of the HMGB1-YAP-HIF1α pathway confers protection against excessive glycolysis and tumor growth in mice. CONCLUSION: These findings demonstrate that HMGB1 plays a novel role in modulating the YAP-dependent HIF1α pathway and shed light on the development of metabolism-targeting therapeutics for HCC chemoprevention. (Hepatology 2018;67:1823-1841).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Chen R, Zhu S, Fan XG, et al. High mobility group protein B1 controls liver cancer initiation through yes-associated protein -dependent aerobic glycolysis. Hepatology. 2018. PMID: 29149457. doi:10.1002/hep.29663

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。